Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial
Crossref DOI link: https://doi.org/10.1136/bmjopen-2015-008405
Published Online: 2015-09-14
Published Print: 2015-09
Update policy: https://doi.org/10.1136/crossmarkpolicy
Sivaprasad, Sobha
Prevost, A Toby
Bainbridge, James
Edwards, Rhiannon Tudor
Hopkins, David
Kelly, Joanna
Luthert, Phil
Murphy, Caroline
Ramu, Jayashree
Sarafraz-Shekary, Negin
Vasconcelos, Joana
White-Alao, Beverley
Hykin, Philip